Last Updated: September 24, 2026

CAPREOMYCIN SULFATE Drug Patent Profile

Name: CAPREOMYCIN SULFATE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Capreomycin Sulfate patents expire, and when can generic versions of Capreomycin Sulfate launch?

Capreomycin Sulfate is a drug marketed by Hisun Pharm Hangzhou and Pharmobedient and is included in two NDAs.

The generic ingredient in CAPREOMYCIN SULFATE is capreomycin sulfate. There is one drug master file entry for this compound. Additional details are available on the capreomycin sulfate profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CAPREOMYCIN SULFATE?
What are the global sales for CAPREOMYCIN SULFATE?
What is Average Wholesale Price for CAPREOMYCIN SULFATE?

Summary for CAPREOMYCIN SULFATE

US Patents:	0
Applicants:	2
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	8
Clinical Trials:	1
DailyMed Link:	CAPREOMYCIN SULFATE at DailyMed

Drug patent expirations by year for CAPREOMYCIN SULFATE

Recent Clinical Trials for CAPREOMYCIN SULFATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Institute of Allergy and Infectious Diseases (NIAID)	N/A

See all CAPREOMYCIN SULFATE clinical trials

Medical Subject Heading (MeSH) Categories for CAPREOMYCIN SULFATE

Anti-Bacterial Agents
Antibiotics, Antitubercular
Protein Synthesis Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for CAPREOMYCIN SULFATE

J04AB	Antibiotics
J04A	DRUGS FOR TREATMENT OF TUBERCULOSIS
J04	ANTIMYCOBACTERIALS
J	Antiinfectives for systemic use

US Patents and Regulatory Information for CAPREOMYCIN SULFATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hisun Pharm Hangzhou	CAPREOMYCIN SULFATE	capreomycin sulfate	INJECTABLE;INJECTION	204796-001	Oct 18, 2018		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Pharmobedient	CAPREOMYCIN SULFATE	capreomycin sulfate	INJECTABLE;INJECTION	202634-001	Nov 27, 2017		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.